Hologic Valuation

HOLX Stock  USD 76.71  0.48  0.62%   
At this time, the firm appears to be fairly valued. Hologic retains a regular Real Value of $75.97 per share. The prevalent price of the firm is $76.71. Our model calculates the value of Hologic from evaluating the firm fundamentals such as Return On Asset of 0.0649, current valuation of 18.65 B, and Return On Equity of 0.11 as well as inspecting its technical indicators and probability of bankruptcy. In general, most investors encourage acquiring undervalued assets and dropping overvalued assets since, at some point, asset prices and their ongoing real values will come together. Key fundamental drivers impacting Hologic's valuation include:
Price Book
3.9014
Enterprise Value
18.6 B
Enterprise Value Ebitda
17.6847
Price Sales
4.5731
Forward PE
19.1205
Fairly Valued
Today
76.71
Please note that Hologic's price fluctuation is very steady at this time. Calculation of the real value of Hologic is based on 3 months time horizon. Increasing Hologic's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Hologic is useful when determining the fair value of the Hologic stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Hologic. Since Hologic is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Hologic Stock. However, Hologic's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  76.71 Real  75.97 Target  86.62 Hype  76.71 Naive  75.66
The real value of Hologic Stock, also known as its intrinsic value, is the underlying worth of Hologic Company, which is reflected in its stock price. It is based on Hologic's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Hologic's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Hologic's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
75.97
Real Value
77.12
Upside
Estimating the potential upside or downside of Hologic helps investors to forecast how Hologic stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Hologic more accurately as focusing exclusively on Hologic's fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
0.960.981.00
Details
Hype
Prediction
LowEstimatedHigh
75.5676.7177.86
Details
Naive
Forecast
LowNext ValueHigh
74.5175.6676.80
Details
18 Analysts
Consensus
LowTarget PriceHigh
78.8286.6296.15
Details
Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Hologic's intrinsic value based on its ongoing forecasts of Hologic's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Hologic's closest peers. When choosing an evaluation method for Hologic, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.

Hologic Investments

(143.73 Million)

Hologic Valuation Trend

Knowing Hologic's actual value is paramount for traders to make sound investment determinations. Hologic's real value is not only important for the investor to make better decisions but also for a more accurate overall view of Hologic's financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Hologic's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.

Hologic Market Cap

Hologic is one of the top stocks in market capitalization category among related companies. Market capitalization of Health Care industry is currently estimated at about 25.23 Billion. Hologic totals roughly 18.01 Billion in market capitalization claiming about 71% of equities under Health Care industry.
Capitalization  Workforce  Valuation  Total debt  Revenue

Hologic Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Hologic's current stock value. Our valuation model uses many indicators to compare Hologic value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Hologic competition to find correlations between indicators driving Hologic's intrinsic value. More Info.
Hologic is rated # 4 in price to earning category among related companies. It is rated # 4 in price to book category among related companies fabricating about  0.38  of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Hologic is roughly  2.62 . Price To Book Ratio is likely to drop to 3.73 in 2024. Comparative valuation analysis is a catch-all model that can be used if you cannot value Hologic by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Hologic's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Hologic's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Hologic's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Hologic and how it compares across the competition.

About Hologic Valuation

The stock valuation mechanism determines the current worth of Hologic on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Hologic. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Hologic based exclusively on its fundamental and basic technical indicators. By analyzing Hologic's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Hologic's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Hologic. We calculate exposure to Hologic's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Hologic's related companies.
Last ReportedProjected for Next Year
Gross Profit2.4 B2.5 B
Pretax Profit Margin 0.15  0.16 
Operating Profit Margin 0.15  0.16 
Net Profit Margin 0.10  0.11 
Gross Profit Margin 0.46  0.39 

8 Steps to conduct Hologic's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Hologic's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Hologic's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Hologic's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Hologic's revenue streams: Identify Hologic's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Hologic's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Hologic's growth potential: Evaluate Hologic's management, business model, and growth potential.
  • Determine Hologic's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Hologic's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Hologic Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Hologic does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding248.8 M
Quarterly Earnings Growth Y O Y0.373
Forward Price Earnings19.1205

Hologic Current Valuation Indicators

Valuation refers to the process of determining the present value of Hologic and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Hologic we look at many different elements of the entity such as Hologic's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Hologic's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Hologic's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Hologic, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Hologic's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Hologic's worth.
When determining whether Hologic offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Hologic's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Hologic Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Hologic Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hologic. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For more information on how to buy Hologic Stock please use our How to Invest in Hologic guide.
You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Complementary Tools for Hologic Stock analysis

When running Hologic's price analysis, check to measure Hologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hologic is operating at the current time. Most of Hologic's value examination focuses on studying past and present price action to predict the probability of Hologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hologic's price. Additionally, you may evaluate how the addition of Hologic to your portfolios can decrease your overall portfolio volatility.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Bonds Directory
Find actively traded corporate debentures issued by US companies
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Fundamental Analysis
View fundamental data based on most recent published financial statements
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Is Hologic's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hologic. If investors know Hologic will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hologic listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.373
Earnings Share
2.11
Revenue Per Share
16.228
Quarterly Revenue Growth
(0.06)
Return On Assets
0.0649
The market value of Hologic is measured differently than its book value, which is the value of Hologic that is recorded on the company's balance sheet. Investors also form their own opinion of Hologic's value that differs from its market value or its book value, called intrinsic value, which is Hologic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hologic's market value can be influenced by many factors that don't directly affect Hologic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hologic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Hologic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hologic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.